The technique offers a potential approach to treat infections by multi-drug resistant bacteria.
Researchers from North Carolina State University have developed a de facto antibiotic “smart bomb” that can identify specific strains of bacteria and sever their DNA, eliminating the infection. The technique offers a potential approach to treat infections by multi-drug resistant bacteria.
“Conventional antibiotic treatments kill both ‘good’ and ‘bad’ bacteria, leading to unintended consequences, such as opportunistic infections,” says Dr. Chase Beisel, an assistant professor of chemical and biomolecular engineering at NC State and senior author of a paper describing the work. “What we’ve shown in this new work is that it is possible to selectively remove specific strains of bacteria without affecting populations of good bacteria.”
The new approach works by taking advantage of a part of an immune system present in many bacteria called the CRISPR-Cas system. The CRISPR-Cas system protects bacteria from invaders such as viruses by creating small strands of RNA called CRISPR RNAs, which match DNA sequences specific to a given invader. When those CRISPR RNAs find a match, they unleash Cas proteins that cut the DNA.
The NC State researchers have demonstrated that designing CRISPR RNAs to target DNA sequences in the bacteria themselves causes bacterial suicide, as a bacterium’s CRISPR-Cas system attacks its own DNA.
“In lab testing, we found that this approach removes the targeted bacteria,” Beisel says. “We’re still trying to understand precisely how severing the DNA leads to elimination of the bacteria. However, we’re encouraged by the ease in specifically targeting different bacteria and the potency of elimination.”
The researchers tested the approach in controlled cultures with different combinations of bacteria present, and were able to eliminate only the targeted strain. “For example, we were able to eliminate Salmonella in a culture without affecting good bacteria normally found in the digestive tract,” Beisel says.
The researchers were also able to demonstrate the precision of the technique by eliminating one strain of a species, but not another strain of the same species which shares 99 percent of the same DNA.
Another benefit of the approach, Beisel says, is that “by targeting specific DNA strands through the CRISPR-Cas system, we’re able to bypass the mechanisms underlying the many examples of antibiotic resistance.”
The researchers are currently working to develop effective methods for delivering the CRISPR RNAs in clinical settings.
“This sets the stage for next-generation antibiotics using programmable CRISPR-Cas systems,” says Dr. Rodolphe Barrangou, an associate professor of food, bioprocessing and nutrition sciences at NC State and co-author of the manuscript.
The Latest on: Multi-drug resistant bacteria
via Google News
The Latest on: Multi-drug resistant bacteria
- San Antonio Spurs Deploy Xenex Germ-Zapping Robots; First NBA Team to Use LightStrike Robots to Disinfect Arenaon January 15, 2021 at 5:50 am
NBA season is underway and the San Antonio Spurs have added powerful new teammates with extraordinary germ-zapping capabilities. As part of its comprehensive strategy to minimize risk for fans, arena ...
- Spero: Tebipenem HBr's H2 2021 NDA, SPR720's Phase 2a Data Release And Moreon January 13, 2021 at 8:26 pm
Spero is running three clinical phase therapeutic programs including Tebipenem HBr - Phase 3 [complete] for cUTIs, SPR720 - Phase 2a for NMT-PD, and SPR206 - Phase 1 for MDRi. Spero has maintained a ...
- A mission to conquer tuberculosis and sleeping sickness in developing nationson January 13, 2021 at 4:06 pm
This article is an excerpt from the research magazine "Tackling Global Issues vol.3 Fighting the menace of zoonosis." Click here to see the table ...
- Drug-resistant superbugs are spreading, and faston January 13, 2021 at 3:14 pm
Found in human skin, researchers discovered three variants of the multi-drug resistant bug ... warning about different strains of drug-resistant bacteria. For India, this is a serious problem.
- Global Multidrug Resistant Bacteria Treatment Market 2020 Key Business Opportunities, Impressive Growth Rate and Development Analysis to 2025on January 12, 2021 at 3:48 pm
Global Multidrug Resistant Bacteria Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025 provides a comprehensive assessment of market values, with corrective calculations ...
- Superbugs have an arsenal of defences – but we’ve found a new way around themon January 11, 2021 at 7:58 pm
Researchers have not discovered new antibiotics in decades. But our new research, published today in Nature Microbiology, has found a way to give ...
- Iterum Therapeutics to Participate in H.C. Wainwright BioConnect Virtual Conferenceon January 7, 2021 at 8:01 am
(GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections ...
- Iterum Therapeutics to Participate in H.C. Wainwright BioConnect Virtual Conferenceon January 6, 2021 at 2:06 pm
(the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community ...
- Essential Science: Immuno-antibiotics, the answer to resistance?on December 27, 2020 at 4:00 pm
Of particular concern are multi-drug resistant organisms (MDROs). These are bacteria that are resistant to one or more of the antibiotics used to treat them. n MDROs can develop when antibiotics ...
via Bing News